期刊文献+

糖尿病急性心肌梗死患者的临床特点及随访研究 被引量:18

Clinical features and follow-up study on diabetic patients with acute myocardial infarction
下载PDF
导出
摘要 目的:探讨糖尿病急性心肌梗死患者的临床特点,分析植入药物洗脱支架后1年的随访情况。方法:将入选的350名急性心肌梗死患者分为两组,其中糖尿病组107人,非糖尿病组243人。所有患者均植入药物洗脱支架,对两组患者的临床危险因素及1年随访结果进行分析。结果:糖尿病组比非糖尿病组患者年龄大[(65.50±12.73)vs(60.80±14.38)岁,P=0.004]、男性比例少(58.5%vs 70.1%,P=0.012)、吸烟比例高(38.3%vs 24.3%,P=0.007),更易合并高血压病(84.1%vs 76.1%,P<0.001)、高脂血症(89.7%vs 79.0%,P=0.016)、慢性肾功能不全(24.3%vs 8.2%,P<0.001)等情况。糖尿病组比非糖尿病组3支病变比例高(41.1%vs 29.6%,P=0.035)、单支病变比例低(27.1%vs 44.4%,P=0.002)。糖尿病组主要心脏不良事件总的发生率高于非糖尿病组(19.6%vs 9.5%,P=0.008),其中全因性死亡是主导事件(13.1%vs 4.5%,P=0.004)。两组患者靶病变血运重建(4.7%vs 4.5%,P=0.952)、靶血管血运重建(12.1%vs 7.8%,P=0.195)、再次心肌梗死(1.9%vs 0.4%,P=0.173)、支架内再狭窄(2.8%vs 2.9%,P=0.968)、支架内血栓形成(1.9%vs 1.6%,P=0.882)的发生率没有显著差异。结论:糖尿病急性心肌梗死患者比非糖尿病急性心肌梗死患者平均年龄大,且女性、吸烟、高血压、高血脂、肾功能不全、3支病变的比例均高于后者,药物洗脱支架没有增加糖尿病急性心肌梗死患者再次心肌梗死、血运重建、支架内再狭窄、支架内血栓形成的发生率,但其主要心脏不良事件总的发生率比非糖尿病急性心肌梗死患者高,且主导事件是全因性死亡。 Objective:To evaluate the clinical characteristics of diabetic patients with acute myocardial infarction and the incidence of MACE after being treated with drug-eluting stents .Methods:350 patients who presented with acute myocardial infarction and were treated with drug-eluting stents were classified into 2 groups according to the&amp;nbsp;presence or absence of DM .The clinical characteristics and one-year follow-up results in the two groups were analyzed.Results:The patients with DM were older than the patients without DM [(65.50 ±12.73)vs(60.80 ± 14.38),P=0.004].The ratio of male patients was lower in the DM group (58.5%vs 70.1%,P=0.012)and the ratio of smoking ( 38.3% vs 24.3%, P =0.007 ) , hypertension ( 84.1% vs 76.1%, P 〈0.001 ) , hyperlipidemia (89.7%vs 79.0%,P=0.016),chronic renal insufficiency (24.3% vs 8.2%,P〈0.001) was higher in the DM group.The incidence of multi-vessel disease was higher in the DM group (41.1%vs 29.6%,P=0.035) ,but the incidence of one-vessel disease was higher in the non-DM group (27.1%vs 44.4%,P=0.002).The incidence of composite MACE of one year was higher in the DM group (19.6%vs 9.5%,P=0.008).The incidence of death of one year was higher in the DM group (13.1% vs 4.5%,P=0.004).Conclusion: The DM patients with AMI is older and have higher ratio of female gender ,smoking,hypertension,hyperlipidemia and chronic renal insufficiency than the non-DM patients with AMI;Compared to the non-DM patients with AMI ,the DM patients with AMI show a preponderance of multi-vessel disease , the drug-eluting stent does not increase the incidence of myocardial infarction,target lesion revascularization , restenosis and stent thrombosis in the DM group .The incidence of composite MACE of one year is higher in the DM group , the all-case death are the dominant event .
出处 《东南大学学报(医学版)》 CAS 2014年第2期182-186,共5页 Journal of Southeast University(Medical Science Edition)
关键词 急性心肌梗死 糖尿病 药物洗脱支架 随访 acute myocardial infarction diabetes mellitus drug-eluting stent follow-up
  • 相关文献

参考文献2

二级参考文献25

  • 1ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun ZHENG Ai-fang ZHANG Xian SHEN Wei-feng.Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years[J].Chinese Medical Journal,2006(14):1151-1156. 被引量:54
  • 2KEELEY E C, BOURA J A, GRINES C L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : aquantitative review of 23 randomised trials [ J 1. Lancet, 2003,361 ( 9351 ) : 13- 20.
  • 3HOI,MES J R, KEREIAKES D J, GARG S, et al. Stent throm-bosis[ J. J Am Coll Cardiol,2010,56(17) :1357-1365.
  • 4COOK S,WENAWESER P, TOGNI M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation[ J ]. Circulation ,2007,115 ( 18 ) :2426-2434.
  • 5SANTOS M, LIN T, BARLIS P. In-stent restenosis associated with stent malapposition: seven year optical coherence tomo- graphy findings [ J 1- Int J Cardio1,2011,147 ( 1 ) : 149-151.
  • 6ROUKOZ H, BAVRY A A,SARKEES M L, et al. Comprehen- sive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow- up [ J ]. Am J Med, 2009, 122 (6) :581. el-10.
  • 7KIRTANE A J, GUPTA A,IYENGAR S, et al. Safety and effi- cacy of drug-eluting and bare metal stents:comprehensive me- ta- analysis of randomized trials and observational studies [ J ]. Circulation, 2009,119 ( 25 ) : 3198- 3206.
  • 8BAKHAI A, STONE G W, MAHONEY E,et al. Cost effective- ness of paclitaxel-eluting stents for patients undergoing percu- taneous coronary revascularization: results from the TAXUS- IV Trial[ J]. J Am Coll Cardiol,2006,48(2) :253-261.
  • 9EISENSTEIN E L, WIJNS W, FAJAET J, et al. Long-term clin- ical and economic analysis of the Endeavor drug-eluting stent versus the driver bare-metal stent:4-year results from the EN- DEAVOR II trial (randomized controlled trial to evaluatethe safety and efficacy of the medtronic AVE ABT-578 eluting driver coronary stent in de novo native coronary artery lesions) [ J ]. JACC Cardiovasc Interv ,2009,2 ( 12 ) : 1178-1187.
  • 10SUZUKI T, KOPIA G, HAYASHI S, et al. Stent -based delivery of sirolimus reduces neointimal formation in a porcine coronary model [ J 1- Circulation,2001,104 ( 10 ) : 1188-1193.

共引文献12

同被引文献154

引证文献18

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部